Loading…
GoHealth, Inc. is projected to decline to $0.5793 by 2027, a -11% move from its current price of $0.6534. GOCO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.6201 | $0.6537 | $0.6891 | +0.04% |
| May 30 | $0.607 | $0.654 | $0.7046 | +0.09% |
| May 31 | $0.5972 | $0.6543 | $0.7168 | +0.13% |
| Jun 1 | $0.5891 | $0.6546 | $0.7273 | +0.18% |
| Jun 2 | $0.5821 | $0.6549 | $0.7367 | +0.22% |
| Jun 3 | $0.5758 | $0.6552 | $0.7454 | +0.27% |
| Jun 4 | $0.5702 | $0.6554 | $0.7535 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.5702 | $0.6554 | $0.7535 | +0.31% |
| Week 2 | $0.5399 | $0.6575 | $0.8008 | +0.63% |
| Week 3 | $0.5181 | $0.6595 | $0.8397 | +0.94% |
| Week 4 | $0.5006 | $0.6616 | $0.8743 | +1.26% |
| Week 5 | $0.4859 | $0.6637 | $0.9064 | +1.57% |
| Week 6 | $0.4732 | $0.6658 | $0.9367 | +1.89% |
| Week 7 | $0.4618 | $0.6678 | $0.9657 | +2.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. It offers Medicare plans, including Medicare advantage, Medicare supplement, prescription drug plans, and special needs plans.
It also operates a technology platform that leverages machine-learning algorithms of insurance purchasing behavior to reimagine the process of matching a health plan for a consumer's specific needs. In addition, the company offers partner marketing services.
GoHealth was founded in 2001 and is headquartered in Chicago, Illinois. It sells its products through internal and external agencies, as well as its platform.
GoHealth, Inc. is currently priced at $0.6546 with a market cap of $19.18M, and it ranks 4956. The stock’s current price and market position provide context for assessing the immediate trading stance and relative size in the market.
The forecasted price path shows a mixed near-term outlook and a clearer long-term upside, with 2026 averaging $0.6546 and a gradual rise into higher years. Bullish momentum appears in select years such as 2029 and beyond, culminating in a 2050 average near $1.77 and a max forecast of $4.07, suggesting meaningful upside over the multi-year horizon.
Overall, the annualized view points to potential upside with significant year-by-year variation; the 2050 maximum of $4.07 represents the upper bound of the modeled path, while near-term prices hover closer to the current level.
A major floor 67.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.2% below — buyers have tended to step in here.
The nearest ceiling, 92.8% above — a clean break opens room to run.
A major ceiling 285.7% above — clearing it would confirm fresh momentum.
Key GOCO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GOCO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6592 | Sell | $0.6847 | Sell |
| MA 10 | $0.7492 | Sell | $0.7447 | Sell |
| MA 20 | $0.8783 | Sell | $0.8562 | Sell |
| MA 50 | $1.15 | Sell | $1.14 | Sell |
| MA 100 | $1.56 | Sell | $1.66 | Sell |
| MA 200 | $2.79 | Sell | $3.03 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 26.69 | Buy |
| Stoch RSI (14) | 48.48 | Neutral |
| CCI (20) | -114.98 | Sell |
| Williams %R (14) | -92.62 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -28.24 | Sell |
| Bollinger %B (20,2) | 0.14 | Neutral |
| Stochastic %K (14) | 7.38 | Buy |
| TRIX (15) | -1.73 | Sell |
| Awesome (5,34) | -0.33 | Sell |
| Ultimate (7,14,28) | 21.80 | Buy |
| Momentum (10) | -0.21 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 0.62 | Buy |
| ADX (14) | 37.44 | Sell |
| ATR (14) | 0.04 | Info |
Technical sentiment is NEUTRAL. The RSI14 is 20, and the moving averages show SMA50 at $1.19 and SMA200 at $2.84. Support is at $0.626 and resistance at $1.26. The 30-day range runs from a low of $0.4576 to a high of $0.9365. Annualized volatility is 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.626 | $0.6534 | $0.7351 | 0% | Neutral | |
| $0.418 | $0.5793 | $0.8684 | -11% | Neutral | |
| $0.4622 | $0.679 | $1.08 | +4% | Neutral | |
| $0.5198 | $0.8031 | $1.34 | +23% | Bullish | |
| $0.5046 | $0.8164 | $1.42 | +25% | Bullish | |
| $0.4617 | $0.7798 | $1.40 | +19% | Neutral | |
| $0.4367 | $0.7684 | $1.42 | +18% | Neutral | |
| $0.3586 | $0.6565 | $1.25 | 0% | Neutral | |
| $0.3854 | $0.7333 | $1.43 | +12% | Neutral | |
| $0.5179 | $1.02 | $2.04 | +57% | Bullish | |
| $0.4837 | $1.07 | $2.35 | +65% | Bullish | |
| $0.8046 | $1.79 | $4.11 | +174% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.626 | $0.6534 | $0.7715 | +0.00% |
| June 2026 | $0.5415 | $0.649 | $0.8058 | -0.67% |
| July 2026 | $0.5584 | $0.6805 | $0.8663 | +4.85% |
| August 2026 | $0.5292 | $0.6534 | $0.8478 | -3.98% |
| September 2026 | $0.4753 | $0.5933 | $0.7817 | -9.20% |
| October 2026 | $0.4632 | $0.584 | $0.7802 | -1.56% |
| November 2026 | $0.4598 | $0.585 | $0.7908 | +0.16% |
| December 2026 | $0.419 | $0.5376 | $0.7351 | -8.09% |
Click any year to see its month-by-month GOCO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
GoHealth, Inc.'s 2026 outlook centres on $0.6534, within a $0.626 to $0.7351 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, GOCO could reach as high as $0.8684, with a base case around $0.5793 and support toward $0.418 — roughly -11% from $0.6534. Price action looks broadly range-bound.
Expect GOCO to range from $0.4622 to $1.08 through 2028. The $0.679 average target implies a +4% move from current prices. That is up +17% on the projected 2027 average. A consolidation phase looks the most probable path here.
The GOCO price prediction for 2029 points to an average of $0.8031 (low $0.5198, high $1.34) — a potential gain of +23% on today's $0.6534. Momentum favours further upside here.
In 2030, GOCO is projected to trade between $0.5046 and $1.42, averaging $0.8164 — a potential gain of +25% from today's $0.6534. That is up +2% on the projected 2029 average. Buyers look set to stay in control over this stretch.
GoHealth, Inc.'s 2031 outlook centres on $0.7798, within a $0.4617 to $1.40 range. That is -4% versus the projected 2030 average. That marks a +19% change versus current levels. Price action looks broadly range-bound.
By 2032, GOCO could reach as high as $1.42, with a base case around $0.7684 and support toward $0.4367 — roughly +18% from $0.6534. A consolidation phase looks the most probable path here.
Expect GOCO to range from $0.3586 to $1.25 through 2033. The $0.6565 average target implies a 0% move from current prices. That is -15% versus the projected 2032 average. Price action looks broadly range-bound.
The GOCO price prediction for 2034 points to an average of $0.7333 (low $0.3854, high $1.43) — a potential gain of +12% on today's $0.6534. A consolidation phase looks the most probable path here.
In 2035, GOCO is projected to trade between $0.5179 and $2.04, averaging $1.02 — a potential gain of +57% from today's $0.6534. That is up +40% on the projected 2034 average. Momentum favours further upside here.
GoHealth, Inc.'s 2040 outlook centres on $1.07, within a $0.4837 to $2.35 range. That is up +5% on the projected 2035 average. That marks a +65% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, GOCO could reach as high as $4.11, with a base case around $1.79 and support toward $0.8046 — roughly +174% from $0.6534. Momentum favours further upside here.
Investing $1,000 in GOCO today (≈ 1,530.456076 GOCO) could be worth
$2,736.49
+$1,736.49 (+174%) by 2050 · US Dollar
Based on the average projected GOCO price of $1.79 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GOCOwould be worth at today's price.
$1,000 invested in GOCO on May 27, 2025 (≈ 158.982513 GOCO) would be worth
$103.88
-$896.12 (-89.6%) today · 0.10× · US Dollar
Based on a GOCO entry price of $6.29 vs. today's $0.6534.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.626 | $1,043.77 | +4.4% |
| 1 month ago | $1.17 | $558.46 | -44.2% |
| 3 months ago | $1.44 | $453.75 | -54.6% |
| 6 months ago | $3 | $217.8 | -78.2% |
| 1 year ago | $6.29 | $103.88 | -89.6% |
| All time (5.0y) ago | $166.2 | $3.93 | -99.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GOCO forecast.
Our base-case forecast reaches $1.30 around 2050.
Implied market cap at $1.30: $21.69M
The multi-year forecast reflects a shift from Neutral in the early years to Bullish in several later years. In 2029 the outlook is Bullish with min $0.5133, avg $0.7973, max $1.34 and ROI 21.8. In 2030 the forecast remains Bullish with min $0.5093, avg $0.829, max $1.45 and ROI 26.6.
By 2035, the path remains Bullish with min $0.5146, avg $1.03, max $2.06 and ROI 56.9; 2040 shows min $0.4828, avg $1.07, max $2.36 and ROI 63.9. By 2050, the forecast is Bullish with min $0.7963, avg $1.77, max $4.07 and ROI 170.3.
These figures illustrate meaningful upside potential over the long term, with higher average prices and larger ROIs in the later years. While the numbers provide a framework for possible outcomes, they are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
2030 forecast: min $0.5093, avg $0.829, max $1.45, ROI 26.6, sentiment BULLISH.
Forecasts show Neutral in 2026-2028 and 2031-2032, with Bullish sentiment in 2029, 2030, 2035, 2040, and 2050. Notable long-term upside includes ROI up to 170.3 and a max forecast of $4.07 in 2050.
Yes—the max forecast for 2050 is $4.07.
Current price is $0.6546 and market cap is $19.18M.
The 30-day range is from $0.4576 to $0.9365.
GoHealth, Inc. Community Discussion
0Share your GoHealth, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.